Company / Tangible Book Value per Share
Catalyst Pharmaceuticals Partners, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$7.79
FY2025
5-year range
$2.01 / $7.79
FY2021-FY2025
Trend
+29.4%
vs FY2024
Sector context
#62 of 209
Health Care
What the data says
At $7.79, Catalyst Pharmaceuticals Partners, Inc.'s tangible book value per share ranks #62 of 209 in the Health Care sector. Tangible Book Value per Share has increased for 8 consecutive years, from $0.47 in FY2017 to $7.79 in FY2025.
Based on SEC 10-K filings.
7.79 in FY2025 with a 5-year CAGR of +36.6%.
Improved from $3.62 to $7.79 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +39.7%
- 5-Year CAGR
- +36.6%
- 10-Year CAGR
- -
Sector benchmark
-91.7% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s tangible book value per share has grown for 8 consecutive years.
- In FY2025, tangible book value per share increased 29.4% year-over-year.
- Ranks #62 out of 209 companies in the Health Care sector.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.79 | +29.4% |
| FY2024 | $6.02 | +66.2% |
| FY2023 | $3.62 | +26.9% |
| FY2022 | $2.85 | +42.1% |
| FY2021 | $2.01 | +22.4% |
| FY2020 | $1.64 | +92.3% |
| FY2019 | $0.85 | +72.2% |
| FY2018 | $0.50 | +4.5% |
| FY2017 | $0.47 | +0.0% |
| FY2016 | $0.47 | -29.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026